BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2009316)

  • 1. A method for determination of iododeoxyuridine substitution of thymidine using reversed-phase high-performance liquid chromatography.
    Yabuki H; Nath R
    Cell Prolif; 1991 Jan; 24(1):33-47. PubMed ID: 2009316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Technique for detection of DNA nucleobases by reversed-phase high-performance liquid chromatography optimized for quantitative determination of thymidine substitution by iododeoxyuridine.
    Belanger K; Collins JM; Klecker RW
    J Chromatogr; 1987 Jun; 417(1):57-63. PubMed ID: 3624403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incorporation of iododeoxyuridine into DNA of granulocytes in patients.
    Belanger K; Klecker RW; Rowland J; Kinsella TJ; Collins JM
    Cancer Res; 1986 Dec; 46(12 Pt 1):6509-12. PubMed ID: 3779659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iododeoxyuridine chemosensitization of cis-diamminedichloroplatinum(II) in human bladder cancer cells.
    Chi KH; Kunugi KA; Kinsella TJ
    Cancer Res; 1994 May; 54(10):2701-6. PubMed ID: 8168100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorodeoxyuridine modulation of the incorporation of iododeoxyuridine into DNA of granulocytes: a phase I and clinical pharmacological study.
    Speth PA; Kinsella TJ; Belanger K; Klecker RW; Smith R; Rowland JB; Collins JM
    Cancer Res; 1988 May; 48(10):2933-7. PubMed ID: 2965970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of IdUrd-DNA incorporation and radiosensitization in human bladder carcinoma cells.
    Kunugi KA; Vazquez-Padua MA; Miller EM; Kinsella TJ
    Cancer Res; 1990 Aug; 50(16):4962-7. PubMed ID: 2199032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of thymidine replacement in patients with high grade gliomas, head and neck tumors, and high grade sarcomas after continuous intravenous infusions of 5-iododeoxyuridine.
    Cook JA; Glass J; Lebovics R; Bobo H; Pass H; DeLaney TF; Oldfield EH; Mitchell JB; Glatstein E; Goffman TE
    Cancer Res; 1992 Feb; 52(3):719-25. PubMed ID: 1732059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of leucovorin on idoxuridine cytotoxicity and DNA incorporation.
    Greene RF; Collins JM
    Cancer Res; 1990 Oct; 50(20):6652-6. PubMed ID: 2208128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of base excision repair potentiates iododeoxyuridine-induced cytotoxicity and radiosensitization.
    Taverna P; Hwang HS; Schupp JE; Radivoyevitch T; Session NN; Reddy G; Zarling DA; Kinsella TJ
    Cancer Res; 2003 Feb; 63(4):838-46. PubMed ID: 12591735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of the metabolism and cytotoxicity of iododeoxyuridine by 5'-amino-5'-deoxythymidine.
    Fischer PH; Weddle MA; Mossie RD
    Mol Pharmacol; 1983 May; 23(3):709-16. PubMed ID: 6865913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective radiosensitization of drug-resistant MutS homologue-2 (MSH2) mismatch repair-deficient cells by halogenated thymidine (dThd) analogues: Msh2 mediates dThd analogue DNA levels and the differential cytotoxicity and cell cycle effects of the dThd analogues and 6-thioguanine.
    Berry SE; Davis TW; Schupp JE; Hwang HS; de Wind N; Kinsella TJ
    Cancer Res; 2000 Oct; 60(20):5773-80. PubMed ID: 11059773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thermal sensitivity and radiosensitization in V79 cells after BrdUrd or IdUrd incorporation.
    Raaphorst GP; Vadasz JA; Azzam EI
    Radiat Res; 1984 Apr; 98(1):167-75. PubMed ID: 6718691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of cell labeling and thymidine replacement after continuous infusion of halogenated pyrimidines in vivo.
    Rodriguez R; Ritter MA; Fowler JF; Kinsella TJ
    Int J Radiat Oncol Biol Phys; 1994 Apr; 29(1):105-13. PubMed ID: 8175417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorodeoxyuridine improves imaging of human glioblastoma xenografts with radiolabeled iododeoxyuridine.
    Dupertuis YM; Vazquez M; Mach JP; De Tribolet N; Pichard C; Slosman DO; Buchegger F
    Cancer Res; 2001 Nov; 61(21):7971-7. PubMed ID: 11691821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of radiation damage in cellular DNA following unifilar substitution with iododeoxyuridine.
    Fornace AJ; Dobson PP; Kinsella TJ
    Int J Radiat Oncol Biol Phys; 1990 Apr; 18(4):873-8. PubMed ID: 2323975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved high-affinity monoclonal antibody to iododeoxyuridine.
    Vanderlaan M; Watkins B; Thomas C; Dolbeare F; Stanker L
    Cytometry; 1986 Nov; 7(6):499-507. PubMed ID: 3096672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective incorporation of iododeoxyuridine into DNA of hepatic metastases versus normal human liver.
    Speth PA; Kinsella TJ; Chang AE; Klecker RW; Belanger K; Collins JM
    Clin Pharmacol Ther; 1988 Oct; 44(4):369-75. PubMed ID: 3168389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation of chemotherapy cytotoxicity following iododeoxyuridine incorporation in Chinese hamster cells.
    Russo A; DeGraff W; Kinsella TJ; Gamson J; Glatstein E; Mitchell JB
    Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1371-4. PubMed ID: 3759557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iododeoxyuridine incorporation and radiosensitization in three human tumor cell lines.
    Uhl V; Phillips TL; Ross GY; Bodell WJ; Rasmussen J
    Int J Radiat Oncol Biol Phys; 1992; 22(3):489-94. PubMed ID: 1735685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unlabelled iododeoxyuridine increases the rate of uptake of [125I]iododeoxyuridine in human xenografted glioblastomas.
    Dupertuis YM; Xiao WH; De Tribolet N; Pichard C; Slosman DO; Bischof Delaloye A; Buchegger F
    Eur J Nucl Med Mol Imaging; 2002 Apr; 29(4):499-505. PubMed ID: 11914888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.